Bayliss and Boyd

Deprescribing Education vs Usual Care for Patients with Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized Trial

May 2022 – In Grand Rounds 27, the NIA IMPACT Collaboratory collaborated with the US Deprescribing Research Network (USDeN) to present on the OPTIMIZE Pragmatic Cluster Randomized Trial.

Download Webinar Slides

Speakers

Elizabeth BaylissElizabeth Bayliss, MD, MSPH

Senior Investigator
Institute for Health Research
Kaiser Permanente Colorado

Professor of Family Medicine
University of Colorado School of Medicine

 

Cynthia Boyd, MD, MPHCynthia Boyd, MD, MPH

Professor
Medicine, Epidemiology, and Health Policy & Management

Johns Hopkins University School of Medicine

Learning Objectives

  • Understand the approach used to conduct a pragmatic trial of deprescribing education in primary care
  • Describe cognitively impaired populations that may benefit from deprescribing education in primary care
  • Discuss potential adaptations of a deprescribing education intervention in a large health system